Takashi Kobayashi

Takashi Kobayashi

Auto-generated profile, based on publicly available information

Takashi Kobayashi

Division of Food Science and Biotechnology, Graduate School of Agriculture Kyoto University Sakyo‐ku Kyoto Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Carbohydrate Research
Verified
Journal Article
Closed access
YOYuichiro Onishi
Yuichiro Onishi
YFYuya Furushiro
Yuya Furushiro
YHYusuke Hirayama
Yusuke Hirayama
SAShuji Adachi
Shuji Adachi
TKTakashi Kobayashi
Takashi Kobayashi

31 March 2021 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
YOYuichiro Onishi
Yuichiro Onishi
YFYuya Furushiro
Yuya Furushiro
SAShuji Adachi
Shuji Adachi
TKTakashi Kobayashi
Takashi Kobayashi

5 October 2023 in Journal of Food Engineering
Verified
Journal Article
Closed access
RCRatchanon Chantanuson
Ratchanon Chantanuson
SNShinsuke Nagamine
Shinsuke Nagamine
TKTakashi Kobayashi
Takashi Kobayashi
KNKyuya Nakagawa
Kyuya Nakagawa

1 January 1995 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
TKTakashi Kobayashi
Takashi Kobayashi
TITeruhiko Inoue
Teruhiko Inoue
SNShigeyoshi Nishino
Shigeyoshi Nishino
YFYoshimi Fujihara
Yoshimi Fujihara
KOKiyoshi Oizumi
Kiyoshi Oizumi
TKTomio Kimura
Tomio Kimura
Novel 2-amino-1,4-dihydropyridine derivatives I, which contain N,N,-dialkylaminoalkoxycarbonyl groups at the 3- and/or 5-position, were synthesized and their antihypertensive effects were evaluated in spontaneously hypertensive rats. Remarkably prolonged duration of antihypertensive action was observed when a tertiary amino group was introduced into either the 3- and/or 5-ester side-chain of the 1,4-dihydropyridine ring. In particular, the compounds containing cyclic amino moieties at the 3-position showed greater potency than those with acyclic amino moieties. Chemical modification studies indicated that the two ester side-chains of 1,4-dihydropyridine at the 3- and 5-position might function in a different manner in relation to the antihypertensive activities. 3-(1-Benzhydrylazetidinited potent and long-lasting antihypertensive effects with gradual onset of action, and is a promising candidate as an antihypertensive drug.

13 September 2023 in JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
Verified
Journal Article
Open access
SNShinsuke Nagamine
Shinsuke Nagamine
MAMika Akagi
Mika Akagi
KNKyuya Nakagawa
Kyuya Nakagawa
TKTakashi Kobayashi
Takashi Kobayashi

11 September 2023 in Food Chemistry
Verified
Journal Article
Closed access
YOYuichiro Onishi
Yuichiro Onishi
SAShuji Adachi
Shuji Adachi
FTFumito Tani
Fumito Tani
TKTakashi Kobayashi
Takashi Kobayashi